Tech Company Financing Transactions
TranS1 Funding Round
Advanced Technology Ventures, Cutlass Capital and Delphi Ventures invested in a $12 million Series B venture round for TranS1. The round was announced on 5/6/2003.
Transaction Overview
Company Name
Announced On
5/6/2003
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors
Proceeds Purpose
To complete the development of the company's lumbar spine surgery product scheduled to enter clinical trials later this year.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
110 Horizon Dr. 230
Raleigh, NC 27615
USA
Raleigh, NC 27615
USA
Phone
Website
Email Address
Overview
TranS1 (Nasdaq: TSON) has developed a unique approach to accessing the lumbar spine through a percutaneous opening via the sacral bone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Reali
Chief Financial Officer
Tim Shannon
VP - Marketing
Matthew Pickens
VP - Operations
Greg Welsh
VP - R & D
Stephen Ainsworth
VP - Regulatory Affairs
Stephanie Fitts
Browse more venture capital transactions:
Prev: 5/5/2003: Medidata Solutions venture capital transaction
Next: 5/9/2003: Acorda Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs